John Duncan Higgons's Net Worth

$27.9 Million

Estimate Recalculated Sep 9, 2024 12:26AM EST

Who is John Duncan Higgons

John Duncan Higgons has an estimated net worth of $27.9 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, and Jounce Therapeutics, Inc..

SEC CIK

John Duncan Higgons's CIK is 0001581954

Past Insider Trading and Trends

2015 was John Duncan Higgons's most active year for acquiring shares with 19 total transactions. John Duncan Higgons's most active month to acquire stocks was the month of May. 2014 was John Duncan Higgons's most active year for disposing of shares, totalling 34 transactions. John Duncan Higgons's most active month to dispose stocks was the month of February. 2016 saw John Duncan Higgons paying a total of $195,925.16 for 58,999 shares, this is the most they've acquired in one year. In 2015 John Duncan Higgons cashed out on 402,000 shares for a total of $15,214,986.95, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AGIOS PHARMACEUTICALS INC

Chief Operating Officer
Updated Jan 05, 2016
Form 4
$3.32
$195.93K
Jan 05, 2016
483.04K
Options
Jan 04
Form 4
-24.44%
-20.00K
$50.09
-$1.00M
Dec 17, 2015
61.84K
Sale
ScheduledDec 15
Form 4
16.63%
34.09K
Dec 07, 2015
239.11K
Grant
Dec 03
Form 4
-3.86%
-20.00K
$31.30
-$1.21M
Nov 18, 2015
498.49K
Sale
ScheduledNov 16
Form 4
-2.54%
-20.00K
$35.68
-$1.41M
Oct 19, 2015
768.06K
Sale
ScheduledOct 15
Form 4
-46.10%
-70.00K
Oct 09, 2015
81.84K
Grant
Oct 07
Form 4
$0.30
$3.03K
Oct 02, 2015
396.86K
Options
Sep 30
Form 4
-2.90%
-20.00K
$45.71
-$1.82M
Sep 17, 2015
669.40K
Sale
ScheduledSep 15
Form 4
$0.30
$3.03K
Aug 21, 2015
416.86K
Options
Aug 20
Form 4
-4.58%
-20.00K
$46.27
-$1.84M
Aug 19, 2015
416.86K
Sale
ScheduledAug 17
Form 4
$0.30
$3.03K
Aug 10, 2015
436.86K
Options
Aug 06
Form 4
-4.38%
-20.00K
$57.16
-$2.27M
Jul 17, 2015
436.86K
Sale
ScheduledJul 16
Form 4
-5.43%
-7.00K
$105.23
-$736.61K
Jun 16, 2015
121.84K
Sale
ScheduledJun 15
Form 4
$0.30
$9.08K
Jun 12, 2015
463.86K
Options
Jun 10 - Jun 12
Form 4
-6.98%
-7.42K
$112.89
-$837.31K
May 18, 2015
98.84K
Sale
ScheduledMay 15
Form 4
-5.83%
-6.58K
$99.54
-$655.27K
Apr 17, 2015
106.25K
Sale
ScheduledApr 15
Form 4
-5.84%
-7.00K
$106.24
-$743.68K
Mar 18, 2015
112.84K
Sale
ScheduledMar 16
Form 4
22.89%
68.00K
Mar 03, 2015
365.02K
Grant
Mar 02
Form 4
-9.10%
-12.00K
$110.08
-$1.32M
Jan 06, 2015
119.84K
Sale
ScheduledJan 02
Form 4
-9.10%
-12.00K
$110.08
-$1.32M
Jan 06, 2015
119.84K
Sale
ScheduledJan 02
Form 4
-8.34%
-12.00K
$97.03
-$1.16M
Dec 02, 2014
131.84K
Sale
ScheduledDec 01
Form 4
-8.29%
-13.00K
$81.71
-$1.06M
Nov 04, 2014
143.84K
Sale
ScheduledNov 03
Form 4
-7.65%
-13.00K
$60.07
-$780.91K
Oct 03, 2014
156.84K
Sale
ScheduledOct 01
Form 4
-2.71%
-13.00K
$23.30
-$599.86K
Sep 03, 2014
466.86K
Sale
ScheduledSep 02
Form 4
-1.03%
-5.00K
$22.67
-$223.74K
Aug 28, 2014
479.86K
Sale
ScheduledAug 26
Form 4
-1.42%
-7.00K
$19.70
-$271.51K
Aug 05, 2014
484.86K
Sale
ScheduledAug 01
Form 4
-6.38%
-12.00K
$46.52
-$558.24K
Jul 02, 2014
176.09K
Sale
ScheduledJul 01
Form 4
-2.59%
-5.00K
$45.27
-$226.35K
Jun 16, 2014
188.09K
Sale
ScheduledJun 13
Form 4
-3.50%
-7.00K
$34.47
-$241.31K
Jun 04, 2014
193.09K
Sale
ScheduledJun 02 - Jun 03
Form 4
-2.44%
-5.00K
$45.73
-$228.65K
May 07, 2014
200.09K
Sale
ScheduledMay 06
Form 4
-1.33%
-7.00K
$21.35
-$295.82K
May 05, 2014
520.86K
Sale
ScheduledMay 01
Form 4
5.56%
44.73K
$22.74
-$134.60K
Apr 08, 2014
849.62K
Sell-Options
ScheduledApr 04 - Apr 07
Form 4
-2.42%
-12.00K
$19.19
-$453.33K
Apr 03, 2014
483.13K
Sale
ScheduledApr 01
Form 4
$0.30
$24.20K
Mar 20, 2014
495.13K
Options
Mar 19
Form 4
$0.30
$6.05K
Mar 12, 2014
495.13K
Options
Mar 10
Form 4
7.87%
65.35K
$20.85
-$602.13K
Mar 07, 2014
895.82K
Sell-Options
ScheduledMar 05 - Mar 07
Form 4
-1.83%
-8.00K
$15.08
-$236.41K
Mar 04, 2014
429.78K
Sale
ScheduledMar 03
Form 4
-0.53%
-2.35K
$17.68
-$81.82K
Feb 20, 2014
437.78K
Sale
ScheduledFeb 18
Form 4
-1.79%
-8.00K
$13.14
-$205.31K
Feb 04, 2014
440.13K
Sale
ScheduledFeb 03
Form 4
-2.61%
-12.00K
$17.51
-$412.90K
Jan 23, 2014
448.13K
Sale
ScheduledJan 21
Form 3
Jul 23, 2013
109.09K
Showing 41 results

Jounce Therapeutics, Inc.

Investor
Updated Jun 28, 2022
Form 4
20.00K
Jun 28, 2022
20.00K
Grant
Jun 24
Form 4
15.70K
Jun 22, 2021
15.70K
Grant
Jun 18
Form 4
-2.02%
-200.00
$10.00
-$2.00K
Apr 16, 2021
9.71K
Sale
ScheduledApr 15
Form 4
-1.98%
-200.00
$12.80
-$2.56K
Mar 17, 2021
9.91K
Sale
ScheduledMar 15
Form 4
-1.94%
-200.00
$11.78
-$2.36K
Feb 18, 2021
10.11K
Sale
ScheduledFeb 16
Form 4
-14.15%
-1.70K
$11.90
-$20.22K
Jan 22, 2021
10.31K
Sale
ScheduledJan 20 - Jan 21
Form 4/A
15.70K
Jul 02, 2020
15.70K
Grant
Jun 26
Form 4
13.55K
Jun 29, 2020
13.55K
Grant
Jun 26
Form 4
-11.10%
-1.50K
$8.11
-$12.16K
Jan 08, 2020
12.01K
Sale
ScheduledJan 06
Form 4
15.70K
Jun 13, 2019
15.70K
Grant
Jun 12
Form 4
13.55K
Jun 21, 2018
13.55K
Grant
Jun 19
Form 4
32.96%
6.70K
$16.00
$107.20K
Feb 02, 2017
27.03K
Purchase
Feb 01
Form 3
Jan 26, 2017
20.33K
Showing 13 results